The Current Ratio as of December 2025 (TTM) for Corbus Pharmaceuticals Holdings, Inc. (CRBP) is 9.21

According to Corbus Pharmaceuticals Holdings, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 9.21. This represents a change of -22.94% compared to the average of 11.95 of the last 4 quarters.

Corbus Pharmaceuticals Holdings, Inc. (CRBP) Historical Current Ratio (quarterly & annually)

How has CRBP Current Ratio performed in the past?

The mean historical Current Ratio of Corbus Pharmaceuticals Holdings, Inc. over the last ten years is 4.42. The current 9.21 Current Ratio has changed 20.74% with respect to the historical average. Over the past ten years (40 quarters), CRBP's Current Ratio was at its highest in in the September 2024 quarter at 13.84. The Current Ratio was at its lowest in in the December 2023 quarter at 0.74.

Corbus Pharmaceuticals Holdings, Inc. (CRBP) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Corbus Pharmaceuticals Holdings, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Corbus Pharmaceuticals Holdings, Inc. (CRBP) Average Current Ratio

How has CRBP Current Ratio performed in the past?

The current Current Ratio of Corbus Pharmaceuticals Holdings, Inc. (CRBP) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Corbus Pharmaceuticals Holdings, Inc. (CRBP) Current Ratio vs. Peers

How is CRBP’s Current Ratio compared to its peers?

Corbus Pharmaceuticals Holdings, Inc.’s Current Ratio is greater than Applied Therapeutics, Inc. (0.96), greater than Elicio Therapeutics, Inc. (3.29), less than Molecular Partners AG (9.35), greater than Cardiff Oncology, Inc. (4.20), greater than Rani Therapeutics Holdings, Inc. (0.54), greater than Milestone Pharmaceuticals Inc. (8.24), greater than Forte Biosciences, Inc. (7.34), greater than PepGen Inc. (4.74), greater than Innate Pharma S.A. (2.21), greater than Alector, Inc. (3.76),

Build a custom stock screener for Corbus Pharmaceuticals Holdings, Inc. (CRBP) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Corbus Pharmaceuticals Holdings, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Corbus Pharmaceuticals Holdings, Inc. (CRBP) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Corbus Pharmaceuticals Holdings, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.